I. Kapetanovic

发表

Overview of Commonly Used Bioinformatics Methods and Their Applications

G. Izmirlian, I. Kapetanovic, S. Rosenfeld, 2004, Annals of the New York Academy of Sciences.

Proceedings: The Applications of Bioinformatics in Cancer Detection Workshop

I. Kapetanovic, A. Umar, J. Khan, 2004, Annals of the New York Academy of Sciences.

Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro.

A. Li, I. Kapetanovic, W. Santos, 2002, Chemico-biological interactions.

Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs.

I. Kapetanovic, L. Kopelovich, William D Johnson, 2011, Toxicology.

Determination and stability of CP-31398 in plasma from experimental animals by LC-MS/MS.

I. Kapetanovic, W. Johnson, D. Mccormick, 2011, Journal of pharmaceutical and biomedical analysis.

NMR RELAXATION TIME STUDIES OF SUBSTRATE INTERACTIONS WITH P450 AND OTHER HEMOPROTEINS

I. Kapetanovic, R. Novak, J. Mieyal, 1977 .

Mechanism of valproate‐phenobarbital interaction in epileptic patients

W. Theodore, I. Kapetanovic, J. Penry, 1981, Clinical pharmacology and therapeutics.

Direct quantitation of glucoraphanin in dog and rat plasma by LC-MS/MS.

I. Kapetanovic, D. Mccormick, M. Muzzio, 2010, Journal of pharmaceutical and biomedical analysis.

Murine Oncogenicity and Pharmacokinetics Studies of 9-cis-UAB30, an RXR Agonist, for Breast Cancer Chemoprevention

I. Kapetanovic, W. Johnson, D. Mccormick, 2010, International journal of toxicology.

Systems Biology and Cancer Prevention: All Options on the Table

I. Kapetanovic, S. Rosenfeld, 2008, Gene regulation and systems biology.

Assessment of oral toxicity and safety of 9-cis-UAB30, a potential chemopreventive agent, in rat and dog studies

I. Kapetanovic, A. Lyubimov, T. Martín-Jiménez, 2011, Drug and chemical toxicology.

Methadone in brain and its effects on locomotor activity of young and aged mice

D. Ingram, I. Kapetanovic, L. Middaugh, 1983, Neurobiology of Aging.

Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading.

Y. Liu, Seungpyo Hong, I. Kapetanovic, 2012, Journal of pharmaceutical sciences.

In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes.

I. Kapetanovic, A. Lyubimov, K. Kabirov, 2009, Chemico-biological interactions.

Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats.

I. Kapetanovic, K. Bauer, R. Lubet, 2009, Chemico-biological interactions.

Age effects on haloperidol pharmacokinetics in male, Fischer-344 rats.

I. Kapetanovic, D. Sweeney, S. I. Rapoport, 1982, The Journal of pharmacology and experimental therapeutics.

Oncogenicity Evaluations of Chemopreventive Soy Components in p53(+/–) (p53 knockout) Mice

I. Kapetanovic, J. Crowell, W. Johnson, 2006, International journal of toxicology.

Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.

I. Kapetanovic, D. Mccormick, T. Horn, 2005, Chemico-biological interactions.

Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs.

I. Kapetanovic, J. Crowell, A. Lyubimov, 2009, Toxicology.

Use of stable isotopes and gas chromatography-mass spectrometry in the study of different pools of neurotransmitter amino acids in brain slices.

I. Kapetanovic, W. Yonekawa, H. Kupferberg, 1990, Journal of chromatography.

Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent

I. Kapetanovic, L. Jong, C. Green, 2011, Cancer Chemotherapy and Pharmacology.

Glucuronidation of trans‐resveratrol by human liver and intestinal microsomes and UGT isoforms

I. Kapetanovic, L. Iyer, C. Green, 2006, The Journal of pharmacy and pharmacology.

Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols

V. Steele, I. Kapetanovic, J. Crowell, 2007, Molecular Cancer Therapeutics.

Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

I. Kapetanovic, J. Crowell, W. Johnson, 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.

I. Kapetanovic, J. Crowell, D. Mccormick, 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Metabolic structure-activity relationship for a homologous series of phenacetin analogs.

I. Kapetanovic, J. Strong, J. Mieyal, 1979, The Journal of pharmacology and experimental therapeutics.

Assessment of oral toxicity and safety of pentamethylchromanol (PMCol), a potential chemopreventative agent, in rats and dogs.

I. Kapetanovic, A. Lyubimov, C. Detrisac, 2010, Toxicology.

In‐vitro and in‐vivo metabolic studies of the candidate chemopreventative pentamethylchromanol using liquid chromatography/tandem mass spectrometry

I. Kapetanovic, L. Coward, G. Gorman, 2009 .

In Vitro Metabolic Characterization, Phenotyping, and Kinetic Studies of 9cUAB30, a Retinoid X Receptor-Specific Retinoid

I. Kapetanovic, L. Coward, G. Gorman, 2007, Drug Metabolism and Disposition.

Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography-tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent.

I. Kapetanovic, Hyuntae Kim, Moonsun Kim, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs.

Y. Liu, Seungpyo Hong, I. Kapetanovic, 2013, Current pharmaceutical biotechnology.

Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes.

I. Kapetanovic, K. Bauer, B. Thomas, 2010, Chemico-biological interactions.

Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.

I M Kapetanovic, I. Kapetanovic, 2008, Chemico-biological interactions.

Effects of pharmacological manipulations on basal and newly synthesized levels of GABA, glutamate, aspartate and glutamine in mouse brain cortex.

I. Kapetanovic, C. D. Torchin, W. Yonekawa, 1988, Biochemical pharmacology.

Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.

I. Kapetanovic, W. Johnson, D. Mccormick, 2012, Journal of pharmaceutical and biomedical analysis.

Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.

I. Kapetanovic, J. Crowell, R. Lubet, 2007, Toxicological sciences : an official journal of the Society of Toxicology.

TAMOXIFEN CITRATE + BEXAROTENE IN FEMALE RATS 2 3

I. Kapetanovic, J. Crowell, R. Lubet, 2007 .

Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.

I. Kapetanovic, H. Kupferberg, 1984, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

I. Kapetanovic, D. Mccormick, M. Muzzio, 2011, Cancer Chemotherapy and Pharmacology.

The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro

I. Kapetanovic, W. Yonekawa, H. Kupferberg, 1995, Epilepsy Research.

The effects of anticonvulsant compounds on 4-aminopyridine-induced de novo synthesis of neurotransmitter amino acids in rat hippocampus in vitro

I. Kapetanovic, W. Yonekawa, H. Kupferberg, 1995, Epilepsy Research.

I. Kapetanovic, W. Yonekawa, H. Kupferberg, 1993, Journal of neurochemistry.

Determination of 4-aminobutyric acid, aspartate, glutamate and glutamine and their 13C stable-isotopic enrichment in brain tissue by gas chromatography-mass spectrometry.

I. Kapetanovic, W. Yonekawa, H. Kupferberg, 1987, Journal of chromatography.

Analytical Chemistry Methods: Developments and Validation

Izet M. Kapetanovic, Aleksander V. Lyubimov, I. Kapetanovic, 2010 .

Determination of the N-hydroxy and phenolic metabolites of drugs derived from acetanilide by O-alkylation and selected ion monitoring.

I. Kapetanovic, J. Strong, J. Dutcher, 1977, Analytical chemistry.

Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.

I. Kapetanovic, C. D. Torchin, J. Strong, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Lack of effect of valproate on paracetamol (acetaminophen) disposition in epileptic patients.

W. Theodore, I. Kapetanovic, H. Kupferberg, 1981, British journal of clinical pharmacology.

Analysis of antiepileptic drugs.

I. Kapetanovic, 1990, Journal of chromatography.

Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone

A. Borkhardt, I. Kapetanovic, M. Broggini, 2005, Cancer Chemotherapy and Pharmacology.

Rapid Access to Preventive Intervention Development Program in the Division of Cancer Prevention of the U.S. National Cancer Institute: an Overview

I. Kapetanovic, 2009, Cancer Epidemiology Biomarkers & Prevention.

Evaluation of chemopreventive agents for genotoxic activity.

K. Mortelmans, I. Kapetanovic, J. Crowell, 2007, Mutation research.

Analysis of the antimalarial, mefloquine, in blood and plasma using high-performance liquid chromatography.

I. Kapetanovic, V. Meléndez, J. Bartosevich, 1983, Journal of chromatography.

Identification of [14C]Fluasterone Metabolites in Urine and Feces Collected from Dogs after Subcutaneous and Oral Administration of [14C]Fluasterone

I. Kapetanovic, B. Thomas, A. Lyubimov, 2009, Drug Metabolism and Disposition.

Complete 1H and 13C assignments of fluorinated analogs of dehydroepiandrosterone

I. Kapetanovic, B. Thomas, J. Burgess, 2006, Magnetic resonance in chemistry : MRC.

Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.

I. Kapetanovic, J. Crowell, W. Johnson, 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro.

C. D. Thompson, I. Kapetanovic, T. Macdonald, 1998, Drug metabolism and disposition: the biological fate of chemicals.

Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1

R. Weinshilboum, A. Adjei, I. Kapetanovic, 2008, Drug Metabolism and Disposition.

Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability.

I. Kapetanovic, L. Kopelovich, C. Green, 2012, Chemico-biological interactions.

Analysis of p-hydroxyphenytoin in microsomal reactions by high-performance liquid chromatography with electrochemical detection.

I. Kapetanovic, H. Kupferberg, 1984, Journal of chromatography.

GC and GC-mass spectrometric determination of p-hydroxyphenobarbital extracted from plasma, urine, and hepatic microsomes.

I. Kapetanovic, H. Kupferberg, 1981, Journal of pharmaceutical sciences.

Toxicity of Green Tea Polyphenols

I. Kapetanovic, 2013 .

Identification of [ 14 C]Fluasterone Metabolites in Urine and Feces Collected from Dogs after Subcutaneous and Oral Administration of [ 14 C]Fluasterone

I. Kapetanovic, B. Thomas, A. Lyubimov, 2009 .

GABA‐Mediated Synaptic Interaction Between the Visual and Vestibular Pathways of Hermissenda

D. Alkon, L. Matzel, I. Kapetanovic, 1993, Journal of neurochemistry.

In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices.

I. Kapetanovic, C. D. Torchin, J. Strong, 1997, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys

I. Kapetanovic, L. Jong, J. Crowell, 2010, Cancer Chemotherapy and Pharmacology.

Flunarizine for treatment of partial seizures

J. Sackellares, G. Pledger, S. Schachter, 1994, Neurology.

Pharmacokinetic Profile of Flunarizine After Single and Multiple Dosing in Epileptic Patients Receiving Comedication

D. Treiman, I. Kapetanovic, C. D. Torchin, 1988, Epilepsia.

Automated capillary gas chromatographic determination of flunarizine.

I. Kapetanovic, C. D. Torchin, W. Yonekawa, 1986, Journal of chromatography.

Inhibition of acetaminophen-induced hepatotoxicity by phenacetin and its alkoxy analogs.

I. Kapetanovic, J. Mieyal, 1979, The Journal of pharmacology and experimental therapeutics.

Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity.

Deborah I. Bunin, Jacob E. Wulff, J. McDunn, 2011, Toxicological sciences : an official journal of the Society of Toxicology.

The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro

I. Kapetanovic, W. Yonekawa, H. Kupferberg, 1995, Epilepsy Research.

Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen.

I. Kapetanovic, L. Kopelovich, C. Rao, 2012, Mutation research.

Low-calcemic, efficacious, 1α,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose–response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry

I. Kapetanovic, T. Kensler, Amy A Sarjeant, 2004, Steroids.

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats

I. Kapetanovic, L. Kopelovich, C. Rao, 2012, Cancer Chemotherapy and Pharmacology.

Drug Discovery and Development - Present and Future

Izet M. Kapetanovic, I. Kapetanovic, 2011 .

Comment on 'Resveratrol in human cancer chemoprevention--choosing the 'right' dose'.

I. Kapetanovic, 2012, Molecular Nutrition & Food Research.

Stable isotope methodology and gas chromatography mass spectrometry in a pharmacokinetic study of phenobarbital.

I. Kapetanovic, H. Kupferberg, I M Kapetanović, 1980, Biomedical mass spectrometry.

Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.

I. Kapetanovic, H. Kupferberg, 1985, Drug metabolism and disposition: the biological fate of chemicals.

Inhibition of microsomal phenobarbital metabolism by valproic acid.

I. Kapetanovic, H. Kupferberg, 1981, Biochemical pharmacology.

High-performance liquid chromatographic assay of flunarizine, (E)-1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine, in plasma of epileptic patients.

I. Kapetanovic, C. D. Torchin, W. Yonekawa, 1988, Journal of chromatography.

The clinical value of free phenytoin levels

W. Theodore, I. Kapetanovic, W. Yonekawa, 1985, Annals of neurology.

Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs

I. Kapetanovic, R. V. van Breemen, D. Nikolić, 2013, Drug and chemical toxicology.

Overview of Current Drug Discovery and Development with an Eye towards the Future

Izet M. Kapetanovic, I. Kapetanovic, 2011 .

Comparing pharmacokinetic and pharmacodynamic profiles in female rats orally exposed to lovastatin by gavage versus diet.

I. Kapetanovic, A. Lyubimov, T. Martín-Jiménez, 2008, Chemico-biological interactions.

Effects of oral dosing paradigms (gavage versus diet) on pharmacokinetics and pharmacodynamics.

I. Kapetanovic, R. Krishnaraj, A. Lyubimov, 2006, Chemico-biological interactions.